GenomeUp vs Upscore: Revenue, Funding & Team Size Compared
GenomeUp generates $229.9K in revenue; Upscore generates $222.4K. GenomeUp and Upscore are close to the same size by revenue. The table below compares GenomeUp and Upscore on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  GenomeUpThis company |  Upscore |
|---|---|---|
| Revenue | $229.9K | $222.4K |
| Valuation | Not disclosed | $2.2M |
| Funding raised | $280.5K | Not disclosed |
| Team size | 31 | 9 |
| Founded | 2017 | 2016 |
| HQ | Rome, Italy | Hamburg, Germany |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
GenomeUp at a glance
GenomeUp generates $229.9K in revenue with 31 employees, headquartered in Rome, Italy.
- Revenue
- $229.9K
- Funding
- $280.5K
- Team size
- 31
- Founded
- 2017
GenomeUp is an AI platform for enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24 hours.
Upscore at a glance
Upscore generates $222.4K in revenue with 9 employees, headquartered in Hamburg, Germany.
- Revenue
- $222.4K
- Valuation
- $2.2M
- Team size
- 9
- Founded
- 2016
UpScore provides a comprehensive Content-Intelligence solution to measure, analyze and increase the success of digital content.
Other GenomeUp alternatives
GenomeUp competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
GenomeUp vs Upscore: frequently asked questions
Is GenomeUp or Upscore bigger?
GenomeUp is the bigger company by revenue, at $229.9K against $222.4K for Upscore.
How much revenue does GenomeUp make?
GenomeUp generates $229.9K in annual revenue with a team of 31.
How much revenue does Upscore make?
Upscore generates $222.4K in annual revenue with a team of 9.
How much funding has GenomeUp raised?
GenomeUp has raised $280.5K in total funding since it was founded in 2017.